Selank and Semax are both heptapeptides developed at the Russian Academy of Sciences, both administered intranasally, and both upregulate BDNF — yet they represent fundamentally different pharmacological approaches to brain function research. Understanding their differences is essential for choosing the right tool for specific research questions.
Different Origins, Different Profiles
| Feature | Selank | Semax |
|---|---|---|
| Parent molecule | Tuftsin (immunopeptide) | ACTH(4-10) (neurohormone) |
| Sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro | Met-Glu-His-Phe-Pro-Gly-Pro |
| Primary effect | Anxiolytic | Neurotrophic/cognitive |
| Secondary effect | Cognitive enhancement | Neuroprotection |
| Key pathway | GABAergic + enkephalinergic | BDNF/TrkB + dopaminergic |
| Immune effects | Strong (tuftsin-derived) | Moderate |
| Hormonal effects | None | None (lacks ACTH 1-3) |
| Regulatory status | Approved in Russia (anxiolytic) | Approved in Russia (nootropic/stroke) |
Anxiety Research: Selank's Strength
For anxiolytic research, Selank is the clear choice. Its GABAergic modulation produces anxiolytic effects comparable to low-dose benzodiazepines without sedation or dependence. Semax has modest anxiolytic-like effects but this is not its primary pharmacological profile.
Cognitive Research: Semax's Strength
For pure cognitive enhancement research, Semax shows stronger effects across learning and memory paradigms. Its potent BDNF upregulation and direct neurotrophic activity make it a more targeted tool for studying memory consolidation, synaptic plasticity, and cognitive recovery.
Neuroprotection: Semax's Niche
Semax has extensive stroke and TBI research data that Selank lacks. For cerebrovascular research, ischemia-reperfusion models, or neurodegenerative paradigms, Semax's BDNF-mediated neuroprotective profile is more directly relevant.
Immune Research: Selank's Niche
Selank's tuftsin core gives it genuine immunomodulatory activity — IL-6 modulation, T-cell balance effects, and antiviral properties — that Semax does not share. For neuroimmunology research or studies at the CNS-immune interface, Selank provides a unique dual-action tool.
Both Available at Research Vials
Selank 11mg and Semax 10mg are both available in lyophilized form with full COA documentation.